FDA Approves Zurzuvae, the First Pill for Severe Postpartum Depression The US Food and Drug Administration (FDA) has recently authorized the use of Zurzuvae, a groundbreaking drug for treating severe postpartum depression (PPD). This announcement marks a significant development in the field, as depression can impact even newborns. Zurzuvae, also known by its drug name […]

FDA Approves Zurzuvae: A Breakthrough Pill for Severe Postpartum Depression

Leave a comment

Trending

Discover more from Stay Healthy Weekly

Subscribe now to keep reading and get access to the full archive.

Continue reading